NovaBay Pharmaceuticals logo
NovaBay Pharmaceuticals NBY
€ 0.50 3.99%

Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024

report update icon

NovaBay Pharmaceuticals Kennzahlen 2011-2024 | NBY

Kennzahlen Jährlich NovaBay Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.2 -0.1 -3.2 -1.4 -4.9 -7.7 -2.8 -0.4 -2.1 -2.7 -5.4 -7.1

P/S

0.0 0.2 0.0 3.6 2.0 2.6 3.1 3.0 1.6 30.1 12.5 5.5 3.3

EPS

-4.0 -10.1 -5.3 -0.3 -0.5 -0.4 -0.5 -1.4 -6.8 -7.7 -10.5 -0.2 -0.2

EV (Enterprise Value)

3.18 M 2.96 M 6.78 M 26.6 M 16.5 M 33.5 M 61 M 35 M 15 M 32 M 40.2 M 30.4 M 34.3 M

EBITDA per Share

-1.79 -8.88 -7.06 -0.159 -0.431 -0.449 -0.471 -1.16 -7.49 -8.39 -9.93 -6.76 -3.78

EV/EBITDA

-0.7 -3.7 -1.0 -3.8 -7.4 -2.5 -0.3 -1.6 -2.2 -3.2 -7.1

PEG

-0.0 -0.0 -0.0 0.51 0.06 -0.26 -0.12 -0.03 -0.03 -0.08 0.04 0.27 0.64

P/B

0.2 0.2 0.0 2.9 13.6 6.5 21.9 5.1 -1.4 17.2 5.1 2.7 3.9

P/CF

-0.1 -0.4 -0.1 -7.5 -1.7 -5.8 -8.7 -2.9 -0.4 -2.1 -3.3 -5.7 -11.1

ROE %

-290.89 -100.51 -57.26 -89.62 -992.60 -132.12 -285.39 -185.20 372.17 -822.19 -188.37 -50.02 -54.42

ROA %

-106.71 -64.69 -24.29 -72.44 -86.08 -69.92 -73.45 -85.50 -373.70 -201.59 -102.50 -36.53 -31.85

ROCE %

-229.21 -136.60 -87.13 -51.80 -169.89 -142.75 -143.35 -99.31 -4732.88 -402.62 -128.80 -51.73 -32.92

Current Ratio

1.6 2.8 1.7 5.0 1.6 2.2 1.8 3.3 1.0 2.1 4.1 5.8 5.1

DSO

33.9 25.0 - 40.6 59.0 101.9 74.4 70.1 44.7 94.5 82.3 49.5 0.1

DIO

168.7 183.4 189.4 55.9 103.3 68.0 66.1 129.3 389.3 391.3 520.5 - -

DPO

59.0 58.6 66.6 27.8 69.5 133.8 61.1 67.4 718.7 1400.7 3771.7 - -

Betriebszyklus

202.6 208.4 189.4 96.5 162.3 169.9 140.5 199.4 434.0 485.8 602.8 - -

Finanzkreislauf

143.5 149.9 122.7 68.8 92.8 36.1 79.4 132.0 -284.7 -914.8 -3168.9 - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich NovaBay Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.6 -1.37 -0.15 - -13.11 -44.43 -0.85 - -3.61 -1.43 -0.08 - -0.05 -0.04 -0.04 - -0.08 -0.15 -0.06 - -0.01 -0.14 -0.25 - -0.09 -0.09 -0.13 - -0.16 -0.11 -0.26 - -0.34 -0.36 -1.24 - -1.77 -1.84 -2.13 - -0.08 -0.06 -0.08 - -0.1 -0.11 -0.11 - - -0.08 -0.09 - - 0.02 -0.08

EBITDA per Share

-0.28 -0.9 -0.1 - -5.11 -11.4 -0.65 - -0.27 -1.41 -1.64 - -0.05 -0.04 -0.04 - -0.05 -0.03 -0.05 - -0.07 -0.07 -0.24 - -0.1 -0.12 -0.14 - -0.14 -0.11 -0.25 - -0.19 -0.3 -1.13 - - - -2.12 - -0.08 -0.07 -0.09 - -0.07 -0.11 -0.02 - 0.01 -0.09 -0.08 - - 0.03 -0.08

ROE %

-1889.89 -1801.80 -2082.46 -68.31 -69.29 -45.31 -35.22 -15.30 -39.74 -63.20 -66.10 -54.85 -81.00 -82.70 -102.50 -75.38 -104.36 -107.19 -327.85 -716.55 -747.59 -749.66 -524.69 -106.52 -240.09 -342.61 -377.54 -355.20 -407.81 -326.85 -297.73 -161.99 -59.17 96.27 230.01 -17.23 -245.53 -576.65 -831.72 -580.41 -625.60 -442.48 -330.82 -796.31 -795.74 -749.99 -718.30 -33.29 -32.16 -31.59 -11.20 -15.59 1.13 4.55 -21.28

ROA %

-145.31 -127.72 -100.06 -38.12 -38.73 -25.66 -22.95 -11.06 -29.76 -47.86 -51.52 -43.16 -64.29 -66.73 -82.48 -60.93 -63.45 -44.82 -37.70 -62.14 -78.57 -92.49 -87.17 -56.37 -80.65 -88.50 -88.77 -81.32 -105.61 -105.62 -105.86 -74.79 -178.04 -257.00 -335.77 -256.41 -312.38 -265.11 -207.89 -142.31 -166.90 -135.51 -122.34 -433.32 -432.90 -407.90 -393.60 -24.32 -23.65 -23.40 -9.17 -9.13 0.66 2.66 -12.45

ROCE %

-1460.73 -1371.67 -1554.61 -37.32 -40.64 -34.03 -35.43 -30.41 -54.85 -75.98 -78.90 -54.87 -71.61 -63.90 -56.01 -37.90 -213.85 -373.06 -506.09 -736.07 -772.59 -633.16 -533.48 -126.36 -244.76 -326.64 -352.32 -331.73 -360.76 -271.39 -235.20 -126.07 -21.16 112.77 239.62 -16.68 -239.24 -566.71 -866.89 -648.11 -683.12 -495.57 -339.44 -124.69 -125.45 -91.19 -62.92 -38.91 -42.63 -45.60 -20.43 -19.83 -3.72 4.71 -20.82

Current Ratio

1.4 0.9 1.0 1.6 2.2 2.1 2.5 2.8 2.6 3.7 3.5 1.7 4.3 5.7 4.6 5.2 5.2 5.2 5.2 1.1 1.1 1.1 1.1 2.1 2.1 2.1 2.1 1.4 1.4 1.4 1.4 1.9 1.9 1.9 1.9 0.5 0.5 0.5 1.4 1.3 1.3 1.3 1.3 2.2 2.2 2.2 2.2 3.7 3.7 3.7 3.7 2.4 2.4 2.4 2.4

DSO

23.4 24.4 24.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

63.1 77.0 66.9 - 398.5 189.5 446.6 - 247.4 181.1 208.2 - 105.8 113.8 146.2 - 103.5 27.2 86.4 - 112.0 111.4 103.3 - 77.0 53.3 142.5 - 88.3 65.9 106.8 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

87.8 132.8 110.3 - 135.3 66.8 137.6 - 63.7 62.2 81.3 - 100.1 77.3 113.8 - 51.4 13.5 49.7 - 75.3 75.0 118.0 - 151.4 105.0 184.9 - 81.6 60.9 71.5 - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

86.5 101.3 91.4 - 398.5 189.5 446.6 - 247.4 181.1 208.2 - 105.8 113.8 146.2 - 103.5 27.2 86.4 - 112.0 111.4 103.3 - 77.0 53.3 142.5 - 88.3 65.9 106.8 - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

-1.3 -31.5 -18.9 - 263.2 122.7 309.1 - 183.7 118.9 126.8 - 5.7 36.5 32.4 - 52.1 13.7 36.7 - 36.6 36.5 -14.7 - -74.5 -51.6 -42.4 - 6.7 5.0 35.4 - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung